Oncopharmpod
Fruquintinib And Osimertinib-Chemo in Combo?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:16:58
- Mas informaciones
Informações:
Sinopsis
This week's Pod dives into a new VEGF-R inhibitor, fruquintinib. We also ask if FLAURA2, osimertinib + chemotherapy in combination, will become a new standard of care in EGFR-mutated metastatic NSCLC.
